NewAmsterdam Pharma (NAMS) Other Working Capital Changes (2023 - 2025)

NewAmsterdam Pharma has reported Other Working Capital Changes for 3 years, with the latest figure at $4.0 million in Q4 2025.

• Quarterly Other Working Capital Changes rose 163.52% year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.0 million (up 48.87% YoY) and the FY2025 annual result came in at -$2.0 million, up 48.87% from the prior year.
• Other Working Capital Changes grew to $4.0 million in Q4 2025 per NAMS's latest filing, from -$3.0 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $4.0 million in Q4 2025 and troughed at -$3.2 million in Q1 2023.
• A 3-year average of -$1.3 million and a median of -$1.8 million in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 288.65% in 2024, then plunged 112.56% in 2025.
• Over 3 years, Other Working Capital Changes stood at -$802000.0 in 2023, then soared by 288.65% to $1.5 million in 2024, then jumped by 163.52% to $4.0 million in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $4.0 million, -$3.0 million, and -$3.0 million for Q4 2025, Q2 2025, and Q1 2025 respectively.